Recently, BeiGene announced that the US Food and Drug Administration (FDA) has approved the use of BeiGene (Trastuzumab) in combination with platinum and fluorouracil chemotherapy for first-line treatment of adult patients with unresectable or metastatic HER2 negative gastric or gastroesophageal junction (G/GEJ) cancer expressing PD-L1 (≥ 1).
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Lilly's Alzheimer's disease drug Kisunla approved for sale in the UK
- Puyin International: downgraded BeiGene A-share rating to 'hold', maintaining target price of 181 yuan
- BeiGene: Several new indications for commercial products have been included in the 2024 National Medical Insurance Drug Catalog
- AbbVie: Two new indications for Ruifu (Upatinib Extended Release Tablets) have been added to the national medical insurance catalog in China
- Multiple new indications for Merck drugs approved for market in China
- BeiGene: NASDAQ stock code will be changed to 'ONC'
- BeiGene NASDAQ stock code will be changed to 'ONC'
- BeiGene issues 100000 shares, with an increase of 0.007%
-
"소붕자동차 12월 인도 3만 6695대 동기대비 82% 증가"2024년 12월, 소붕자동차는 도합 3만 6695대의 신차를 인도하여 동기대비 82%, 전월 대비 19% 성장했다.2024년 Q4, 샤오펑자동차의 인도량은 91507대에 달하여 ...- edmond_cn_gd
- 3 일전
- Up
- Down
- Reply
- Favorite
-
"세계 부자 500대 기업의 2024년 재산 총액은 10조 달러를 돌파한다!] 세계에서 가장 부유한 500명은 2024년에 한 걸음 더 나아가 머스크, 저커버그, 황인훈의 인솔하에 이 억만장자들은 새로운 이정표를 향해 나아 ...- 美酒换新诗萄
- 3 일전
- Up
- Down
- Reply
- Favorite
-
베이징상보소식 (기자 관자진 우청연): 1월 1일, 억항지능은 2024회계연도 4분기 및 연간 (2024년 12월 31일까지) 총수입의 초보적수치를 발표했다.2024 회계연도의 4분기 총수입은 1억 6200만 위안으로 당초 예상 ...- 刀与菊滦
- 3 일전
- Up
- Down
- Reply
- Favorite
